May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
CRP and sICAM–1 as Biomarkers in Age–Related Macular Degeneration
Author Affiliations & Notes
  • S.V. Goverdhan
    Human Genetics Division,
    University of Southampton, Southampton, United Kingdom
  • M. Rose–Zerilli
    Human Genetics Division,
    University of Southampton, Southampton, United Kingdom
  • W.M. Howell
    Human Genetics Division,
    University of Southampton, Southampton, United Kingdom
  • K. Avery
    Human Genetics Division,
    University of Southampton, Southampton, United Kingdom
  • V. Chong
    Ophthalmology, Kings College, London, United Kingdom
  • C. Osmong
    MRC epidemiology unit,
    University of Southampton, Southampton, United Kingdom
  • A.J. Lotery
    Human Genetics Division,
    University of Southampton, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships  S.V. Goverdhan, None; M. Rose–Zerilli, None; W.M. Howell, None; K. Avery, None; V. Chong, None; C. Osmong, None; A.J. Lotery, None.
  • Footnotes
    Support  SUHT NHS Junior Research Fellowship,British Council Prevention Blindness
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1147. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.V. Goverdhan, M. Rose–Zerilli, W.M. Howell, K. Avery, V. Chong, C. Osmong, A.J. Lotery; CRP and sICAM–1 as Biomarkers in Age–Related Macular Degeneration . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1147.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate whether CRP (C–Reactive Protein) and sICAM–1 (serum Intercellular Adhesion Molecule–1) biomarkers are independent risk factors for age–related macular degeneration (AMD) and to determine if known functional CRP gene polymorphisms affect CRP levels in AMD. Methods: 319 caucasian subjects with AMD and 442 normal controls, all over the age of 55 were recruited from ophthalmology clinics at the Southampton Eye Unit. AMD phenotypes were characterised by clinical examination, stereoscopic fundus photography, fluorescein angiography and optical coherence tomography. Serum CRP levels were measured using an automated clinical analyser and an sICAM–1 immunoassay was performed using a solid phase ELISA kit. Functional CRP gene polymorphisms +1444C/T and +1059G/C were analysed via a 5’ nuclease TaqMan© PCR genotyping assay using the ABI 7900HT Sequence Detection System. Individuals reporting any infective illness in the preceding month or chronic joint and organ related inflammation were excluded from the CRP analysis. Case–control groups were analysed by logistic regression controlling for age, sex, body mass index and smoking status (current smokers and past smokers). Results: LogCRP values were significantly higher in AMD cases as compared to controls (P=0.002) on multivariate regression analysis. CRP values over 5 mg/l were strongly correlated with AMD (odds ratio=2.6, 95% CI=1.6 to 4.3, P=0.0001). The frequency of +1444 TT genotype was significantly lower in cases (6.2% vs. 11.2%, P=0.03), but neither +1444 nor + 1059 genotypes correlated with serum CRP levels. sICAM levels did not differ significantly in the two groups (mean levels = 301.5 vs. 271.8 units) but current smokers had significantly higher sICAM levels (P=0.0001). Conclusions: Elevated serum CRP > 5 mg/l is significantly associated with AMD. No correlation was observed between CRP polymorphisms +1444C/T and + 1059 G/C and serum CRP levels. sICAM levels do not predict AMD development but are raised in cigarette smokers.

Keywords: age-related macular degeneration • inflammation • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×